In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Quin Wills, Co-founder and CSO of Ochre Bio, a company whose scientists are working in collaboration with AI to unlock the potential of complex human liver data. Ochre's lab in Oxford takes different types of human cells from donor livers, which they combine to build components of the liver from scratch. These ‘bottom up’ models allow them to flexibly study the metabolic, cell death, inflammation, fibrosis, and neoplastic processes that occur throughout the liver disease trajectory. They are, in effect, trying to do the clinical trial before the clinical trial. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.